Your browser doesn't support javascript.
loading
The RA-BE-REAL Multinational, Prospective, Observational Study in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic, or Biologic Disease-Modifying Therapies: a 6-Month Interim Analysis.
Alten, Rieke; Burmester, Gerd R; Matucci-Cerinic, Marco; Salmon, Jean-Hugues; Lopez-Romero, Pedro; Fakhouri, Walid; de la Torre, Inmaculada; Zaremba-Pechmann, Liliana; Holzkämper, Thorsten; Fautrel, Bruno.
Affiliation
  • Alten R; Department of Internal Medicine and Rheumatology, Schlosspark-Klinik, University Medicine Berlin, Berlin, Germany. Rieke.Alten@schlosspark-klinik.de.
  • Burmester GR; Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Matucci-Cerinic M; Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Hospital, Milan, Italy.
  • Salmon JH; Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence, Florence, Italy.
  • Lopez-Romero P; Faculty of Medicine, University of Reims Champagne-Ardenne, UR 3797, 51095, Reims, France.
  • Fakhouri W; Rheumatology Department, Maison Blanche Hospital, Reims University Hospitals, 51092, Reims, France.
  • de la Torre I; Eli Lilly and Company, Indianapolis, IN, USA.
  • Zaremba-Pechmann L; Eli Lilly and Company, Indianapolis, IN, USA.
  • Holzkämper T; Eli Lilly and Company, Indianapolis, IN, USA.
  • Fautrel B; HaaPACS, Schriesheim, Germany.
Rheumatol Ther ; 10(1): 73-93, 2023 Feb.
Article de En | MEDLINE | ID: mdl-36227530

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Observational_studies / Risk_factors_studies Aspects: Patient_preference Langue: En Journal: Rheumatol Ther Année: 2023 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Observational_studies / Risk_factors_studies Aspects: Patient_preference Langue: En Journal: Rheumatol Ther Année: 2023 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: Royaume-Uni